论文部分内容阅读
目的探究在创伤性休克病患的院前急救中使用霍姆复合液(HSH40)所取得的效果。方法择取2013年12月到2015年12月期间于笔者所在急诊接受院前急救的80例创伤性休克病患,按照限制容量复苏时应用的不同药物进行分组:40例使用霍姆复合液的患者归入研究组,40例使用氯化钠注射液的患者归入对照组。组间对比两组患者的相关临床指标。结果研究组的复苏液体用量少于对照组,氧合指数、动脉血乳酸、凝血酶原活化时间均要低于对照组,统计学有差异(P<0.05)。结论在院前急救中为创伤性休克病患使用HSH40可以减少复苏液体用量,促进患者的迅速康复,使其在较短的时间内摆脱休克状态。
Objective To investigate the effect of using Holm complex (HSH40) in prehospital first aid in patients with traumatic shock. Methods Totally 80 patients with traumatic shock who received first-aid at the hospital during their emergency from December 2013 to December 2015 were selected according to the different drugs used to limit the volume of resuscitation: 40 patients with Holm compound Patients were included in the study group, 40 patients with sodium chloride injection in the control group. Comparison of two groups of patients between the clinical indicators. Results The study group had less amount of resuscitation fluid than the control group. The oxygenation index, arterial lactate and prothrombin time were all lower than those of the control group (P <0.05). Conclusions The use of HSH40 in patients with traumatic shock in pre-hospital emergency treatment can reduce the amount of resuscitation fluid and promote the rapid recovery of patients so that they can get rid of shock in a short period of time.